ReviewFrontiers in pharmacology2021

Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA Mutations.

Qin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.